Biotech

All Articles

Vaderis' unusual capillary problem medication lowers nosebleeds

.Vaderis Therapies' goal to create the 1st drug intended specifically at a specific uncommon blood v...

Navigator brings up $100M to cultivate brand new autoimmune pipeline

.Navigator Medicines has actually equipped itself with $one hundred million in series A funds as the...

Duality seeks money for ADC trials as IPO wave spreads to Asia

.China's Duality Biotherapeutics has actually filed (PDF) documents for a Hong Kong IPO, seeking an ...

YolTech offers China legal rights to genetics modifying therapy for $29M

.Four months after Chinese genetics modifying business YolTech Therapies took its cholesterol diseas...

Addex sell climbs after Indivior provides to $300M for material

.Indivior is getting a little molecule allosteric modulator tailored to treat element usage problem ...

Molecular Allies fine-tunes AML test over 'suboptimal exposure'

.Molecular Companions has recognized "suboptimal exposure" to its tetra-specific T-cell engager as t...

Despite combined market, an equity capital revival can be being available in Europe: PitchBook

.While the biotech expenditure performance in Europe has actually reduced somewhat observing a COVID...

8 months after a $213M fundraise, genetics publisher Tome helps make reduces

.After raising $213 million in 2023-- one of the year's biggest personal biotech rounds-- Volume Bio...

BioMarin builds director crew with biotech vets-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of substantial management hirings, shootings an...

Biopharma Q2 VC hit highest degree because '22, while M&ampA slowed down

.Venture capital funding in to biopharma cheered $9.2 billion across 215 deals in the second fourth ...